Cymbalta®

DRUG3 trials

Sponsors

Dr. Reddy's Laboratories Limited, Eurofarma Laboratorios S.A.

Conditions

HealthyPainful Diabetic Peripheral Neuropathy (PDPN)

Phase 1

Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition

CompletedNCT02291367

Dr. Reddy's Laboratories LimitedHealthy

Start: 2008-05-31End: 2008-05-31Updated: 2014-11-14

Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed Condition

CompletedNCT02291341

Dr. Reddy's Laboratories LimitedHealthy

Start: 2008-05-31End: 2008-05-31Updated: 2014-11-14

Phase 3

Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy

WithdrawnNCT06715462

Eurofarma Laboratorios S.A.Painful Diabetic Peripheral Neuropathy (PDPN)

Start: 2026-04-30End: 2028-03-31Updated: 2025-12-18